The Department of Anesthesiology and Perioperative Medicine stresses excellence in research.

Our research efforts are grouped into two categories: basic and translational research, supported mainly by extramural funding and conducted by members of the Division of the Molecular and Translational Biomedicine; and clinical research, conducted by physician scientists as well as clinical faculty in close collaboration with members of the Division of Molecular and Translational Biomedicine under the auspices of the CAAP Program, led by Dr. Michael Froelich.

Areas of Interest

The main goal of the Division of Molecular and Translational Biomedicine is to foster the development of highly innovative research programs spanning from the bench to the bedside, and to the population, which will generate new knowledge, benefit patient care, complement clinical training of residents and fellows, and help launch the careers of new faculty. Members of the division work closely with each other as well as faculty in other School of Medicine departments and schools to enhance the strategic goals of the University of Alabama at Birmingham. In addition, members of the research division worked closely with Dr. Susan Black, Director of the Residency Program, and Dr. Keith A. (Tony) Jones, former chairman of the Department of the Anesthesiology and Perioperative Medicine, to establish the highly successful Resident Academic Career Development Program (RACD) and Resident Mentored Research Experience Track (RMRET), which promote the development of academic anesthesiologists and enable residents to participate in research projects. 

Faculty

In 2014, the department recruited five outstanding scientists  (Jianguo Gu, M.B., Ph.D.; Aftab Ahmad, Ph.D.; Jennifer J. DeBerry, Ph.D.; Kevin S. Harrod, Ph.D.; Shama Ahmad, Ph.D.) who brought with them or recruited a large number of younger faculty, graduate students and postdoctoral fellows, along with significant amounts of NIH funding. In addition, three of the faculty members of this division serve as editors-in-chief of prestigious, society-based peer-reviewed journals. We are also very proud of the fact that two of our colleagues are the previous recipients of the highly prestigious FAER awards.

Members of this division strive to continue to conduct groundbreaking research, expand our extramural support, enhance our interactions with our clinical colleagues, and participate in the teaching of graduate and professional students and in the training of postdoctoral residents and clinical fellows.

How are we doing?

The Division of Molecular and Translational Biomedicine has increased NIH research funding since 2014 to be ranked 10th among U.S. Medical Schools.

 

FY Direct Costs

FY Indirect Costs

FY Total Costs

% Increase

Blue Ridge Institute for Medical Research Rank

2014

835,553

340,138

1,175,691

 

30th

2015

2,311,867

743,090

3,054,957

159.8%

14th

2016

3,563,950

1,236,302

4,800,252

57.1%

10th

2017

3,994,757

1,461,455

5,456,212

14%

10th


Contact

Sadis Matalon, Ph.D., Dr.Sc. (Hon.)Sadis Matalon sqcr
Distinguished Professor and Alice McNeal Endowed Chair of Anesthesiology
Vice Chair for Research, Director, Division of Molecular and Translational Biomedicine
Editor-in-Chief, Physiological Reviews
UAB Department of Anesthesiology and Perioperative Medicine